Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
We examined the effectiveness of uterine artery embolization (UAE) as a primary treatment for small symptomatic myomatas (<50 mm diameter). One hundred patients aged from 29 to 68 years underwent UAE between 01/01/99 and 12/31/2002. Efficacy was judged by physical examination and imaging studies at 6 to 12 months. All the patients were evaluated. Treatment failed in five cases, while symptoms resolved in all the other patients. Five patients became pregnant. The main complication was amenorrhea. No serious adverse effects were observed. The efficacy and safety of this method make it a possible preventive treatment for pre-symptomatic myomata. If these findings are confirmed, they will open a new era in the treatment of fibroids.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!